We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALOY
11951
REalloys Inc
ALOY
$1.02B
$22K ﹤0.01%
+7,396
New +$34.9K
CARM
11952
PUT
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
2,535
+60
+2% +$817
CGEN icon
11953
CALL
Compugen
CGEN
$228M
$22K ﹤0.01%
+33,600
New +$47.5K
CTMX icon
11954
CALL
CytomX Therapeutics
CTMX
$732M
$22K ﹤0.01%
15,300
+600
+4% +$923
CHRN
11955
CALL
ChronoScale Holdings
CHRN
$3.04B
$22K ﹤0.01%
953
-1,594
-63% -$47.1K
GORO icon
11956
PUT
Goldgroup Mining
GORO
$207M
$22K ﹤0.01%
13,600
-13,800
-50% -$23.4K
IKT icon
11957
Inhibikase Therapeutics
IKT
$336M
$22K ﹤0.01%
+4,019
New +$21.1K
KULR icon
11958
PUT
KULR Technology Group
KULR
$122M
$22K ﹤0.01%
2,138
-1,887
-47% -$22.4K
OLOX
11959
CALL
Olenox Industries
OLOX
$3.7M
$22K ﹤0.01%
2
-4
-67% -$46.7K
SLS icon
11960
PUT
SELLAS Life Sciences
SLS
$2.58B
$22K ﹤0.01%
10,700
-100
-0.9% -$276
ZENV
11961
DELISTED
Zenvia
ZENV
$22K ﹤0.01%
+13,845
New +$28.2K
CSLMW
11962
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$22K ﹤0.01%
438,300
+800
+0.2% +$57
TTOO
11963
DELISTED
T2 Biosystems, Inc
TTOO
$22K ﹤0.01%
39
-20
-34% -$13.2K
AFIB
11964
CALL
DELISTED
Acutus Medical Inc
AFIB
$22K ﹤0.01%
25,400
+1,100
+5% +$1.33K
FGH
11965
CALL
DELISTED
FG Group Holdings Inc.
FGH
$22K ﹤0.01%
10,800
-16,300
-60% -$40K
LTCH
11966
DELISTED
Latch, Inc. Common Stock
LTCH
$22K ﹤0.01%
23,392
-1,131,764
-98% -$1.3M
WTT
11967
DELISTED
Wireless Telecom Group, Inc.
WTT
$22K ﹤0.01%
+16,672
New +$23.2K
CYAD
11968
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$22K ﹤0.01%
+16,654
New +$30.6K
LHDX
11969
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$22K ﹤0.01%
21,200
+9,900
+88% +$22.6K
KAL
11970
DELISTED
Kalera Public Limited Company Ordinary Shares
KAL
$22K ﹤0.01%
164
+31
+23% +$8.37K
AHG
11971
Akso Health Group
AHG
$1.09B
$21K ﹤0.01%
+23,209
New +$24.6K
APLT
11972
CALL
DELISTED
Applied Therapeutics
APLT
$21K ﹤0.01%
+22,200
New +$26.6K
AQST icon
11973
Aquestive Therapeutics
AQST
$533M
$21K ﹤0.01%
18,063
-53,932
-75% -$61K
ATOS icon
11974
Atossa Therapeutics
ATOS
$25.9M
$21K ﹤0.01%
1,728
-14,524
-89% -$211K
BARK icon
11975
BARK
BARK
$91.4M
$21K ﹤0.01%
574
-70,662
-99% -$2.61M
477 478
479
480 481

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.